Recursion Pharmaceuticals (RXRX)
(Delayed Data from NSDQ)
$6.67 USD
-0.13 (-1.91%)
Updated Sep 23, 2024 04:00 PM ET
Pre-Market: $6.75 +0.08 (1.20%) 9:18 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.31 | -12.90% |
Earnings Summary
For their last quarter, Recursion Pharmaceuticals (RXRX) reported earnings of -$0.40 per share, missing the Zacks Consensus Estimate of -$0.35 per share. This reflects a negative earnings surprise of 14.29%. Look out for RXRX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.31 per share, reflecting a year-over-year increase of 27.91%.
Earnings History
Price & Consensus
Zacks News for RXRX
Recursion Stock Down Despite Meeting Goal in Brain Disease Study
RXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services